Is Use of Anti-Psychotic Drugs other than Prescribed use Largely Ineffective?

In an article from Agency for Healthcare Research and Quality (AHRQ), there is no credible evidence or any clinical trial that suggests that using of antipsychotics other than prescribed use (colloquially known as ‘off label’) is effective.
The US Food and Drug Administration (FDA) approved second generation, i.e. atypical antipsychotics such as Clozapine, Olanzapine and Aripiprazole for treatment of schizophrenia, bipolar disorder and depression. However, many physicians still prescribe antipsychotics to treat dementia, anxiety disorders and obsessive-compulsive disorders.
There is no good evidence that anti-psychotics relieve or treat conditions other than psychological problems. Using it for substance abuse problems, eating disorders or insomnia may be helpful in controlling symptoms though its safety and efficacy against multiple behavioral conditions is in question.
AHRQ Director Carolyn M. Clancy explained that the report provides additional information that can help clinicians and parents make the possible best decisions. She further warned that individuals should not make assumptions that all atypical antipsychotic medications are similar, because all have their own unique properties and prescribed use.
An editorial based on the report is available in the September issue of Journal of the American Medical Association.

Here is the link to the original article:
http://www.medicalnewstoday.com/articles/235220.php